Reis J P, Selvin E, Pankow J S, Michos E D, Rebholz C M, Lutsey P L
Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD, United States.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Diabetes Metab. 2016 Jun;42(3):162-9. doi: 10.1016/j.diabet.2015.12.004. Epub 2016 Jan 15.
Accumulating evidence has linked elevated parathyroid hormone (PTH) with insulin resistance, beta cell dysfunction and dysglycaemia, however, its role in the development of diabetes is largely unclear, particularly among non-whites. We sought to examine the association of PTH with the incidence of diabetes.
We studied 8066 white and 2034 black adults aged 46-70 years at baseline (1990-92) from the ARIC Study with follow-up for incident diabetes ascertained during study visits conducted in 1993-95 and 1996-98. Hazard ratios (HR) and their 95% CIs for diabetes adjusted for demographics, lifestyle, and 25-hydroxyvitamin D were estimated according to PTH measured at baseline.
PTH was higher among blacks than whites (median [IQR], 43.8 [35.0-55.8] vs. 37.9 [30.4-47.3] pg/mL; P<0.001). During a median follow-up of 6 years, 498 white and 167 black participants developed diabetes. The association of PTH with diabetes varied significantly by race (P-interaction 0.02). PTH was not associated with risk for diabetes among black adults. Among whites, HRs according to quintiles of PTH were 1 (referent), 0.95 (0.71, 1.29), 0.95 (0.70, 1.28), 1.12 (0.84, 1.51), and 1.31 (0.98, 1.76) (P-trend 0.03). When a clinical cut-point for PTH was applied (≥65pg/mL; 5.7% of whites), the HR for diabetes among whites was 1.38 (1.01, 1.88). Results were similar when restricted to participants with normal baseline kidney function.
In this large, population-based study, elevated PTH was independently associated with risk for diabetes among white, but not black adults. Further studies are needed to elucidate the mechanisms that may underlie this differential association of PTH with diabetes across race groups.
越来越多的证据表明,甲状旁腺激素(PTH)升高与胰岛素抵抗、β细胞功能障碍和血糖异常有关,然而,其在糖尿病发生发展中的作用尚不清楚,尤其是在非白人中。我们旨在研究PTH与糖尿病发病率之间的关联。
我们对动脉粥样硬化风险社区研究(ARIC研究)中8066名基线时(1990 - 1992年)年龄在46 - 70岁的白人成年人和2034名黑人成年人进行了研究,并对在1993 - 1995年和1996 - 1998年研究访视期间确诊的糖尿病发病情况进行了随访。根据基线时测量的PTH,估计经人口统计学、生活方式和25 - 羟基维生素D调整后的糖尿病风险比(HR)及其95%置信区间(CI)。
黑人的PTH水平高于白人(中位数[四分位间距],43.8[35.0 - 55.8]对37.9[30.4 - 47.3]pg/mL;P<0.001)。在中位随访6年期间,498名白人参与者和167名黑人参与者患糖尿病。PTH与糖尿病的关联因种族而异(P交互作用 = 0.02)。PTH与黑人成年人患糖尿病的风险无关。在白人中,根据PTH五分位数的HR分别为1(参照)、0.95(0.71,1.29)、0.95(0.70,1.28)、1.12(0.84,1.51)和1.31(0.98,1.76)(P趋势 = 0.03)。当应用PTH的临床切点(≥65pg/mL;占白人的5.7%)时,白人中糖尿病的HR为1.38(1.01,1.88)。在仅限于基线肾功能正常的参与者时,结果相似。
在这项基于人群的大型研究中,PTH升高与白人成年人而非黑人成年人患糖尿病的风险独立相关。需要进一步研究以阐明不同种族组中PTH与糖尿病这种差异关联背后的机制。